DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

102.34 -0.57 (-0.55%)

REAL-TIME: Last trade at

Extended Hours: $102.90 $0.56 (0.55%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

SLXP $102.34 -0.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $102.77
Previous Close $102.91
Daily Range $100.11 - $104.35
52-Week Range $82.52 - $172.98
Market Cap $6.5B
P/E Ratio -81.67
Dividend (Yield) $0.00 (0.0%)
Volume 3,828,130
Average Daily Volume 3,138,998
Current FY EPS -$1.19

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary

Why Salix Pharmaceuticals Ltd. Stock Was Throttled

Salix Pharmaceuticals is today's biggest loser after the company swung and missed badly on its third-quarter earnings results and fourth-quarter guidance.

Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

How Adam Feuerstein Follows The Biotech Sector

Actavis Says 'Let's Make A Deal'

Salix Pharmaceuticals: What Scares Me Most About Its High Inventory & Stock Collapse

Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog

Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection

Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold

See More SLXP News...

SLXP's Top Competitors

SLXP $102.34 (-0.55%)
Current stock: SLXP
JNJ $106.70 (-0.17%)
Current stock: JNJ
NVS $95.04 (0.28%)
Current stock: NVS
RHHBY $37.21 (-0.37%)
Current stock: RHHBY